Searched for
UK MEDICINES AND HEALTHCARE
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 27%As the market seems to be in comeback mode, it helps to be aware that the best (and probably biggest) wealth creator of the last couple of ...- India's weight-loss drug boom raises questions over healthcare prioritiesIndia's market for cheaper anti-obesity drugs has surged tenfold. While demand is high, especially among those with diabetes, concerns abou...
- UK approves Novo weight-loss pill to edge open European marketBritain's medicine regulator has approved Novo Nordisk's weight-loss pill. This makes the UK the first European market for the oral treatme...
- India's biggest trade bet comes with six red flagsIndia may be adding more trade partners, but its latest FTA report card comes with several red marks. A new study by the Global Trade Resea...
- Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
- These large- and mid-cap stocks can give more than 20% return in 1 year, according to analystsHas a peace deal been agreed on by the US and Iran? Will the fragile ceasefire hold? No one can answer these questions with any certainty. ...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Roche brings 7-minute lung cancer shot to IndiaRoche Pharma India introduces a new injectable immunotherapy for lung cancer. This treatment takes only seven minutes, a significant reduct...
- Roche Pharma launches India’s first 7-minute injectable immunotherapy for lung cancerRoche Pharma has introduced Tecentriq, India's first under-the-skin immunotherapy for lung cancer. This new injection takes about seven min...
- 'Thank God' Kiran Mazumdar Shaw did not become a doctor: When Dr Devi Shetty shared a life lesson from Biocon founder's inspiring journeyA missed medical college admission propelled Kiran Mazumdar-Shaw towards a different path, ultimately leading to the founding of Biocon. Re...
- Career advice of the day from famous cardiac surgeon, Dr Devi Shetty: 'When you don't get something, remember that God has something better for you'Renowned doctor Devi Shetty shared a personal story of career setback. He faced rejection for a registrar position in England. This unexpec...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%If you are putting fresh money into the market, it might be a good idea to stay with companies that don't have much to do with global suppl...
- Apollo Hospitals partner with the University of Leicester to establish the Centre for Digital Health & Precision Medicine in IndiaThe Apollo University, Apollo Hospitals, and University of Leicester have launched the Centre for Digital Health and Precision Medicine in ...
- Lupin's arm gets UK regulator nod for COPD treatmentGlobal pharma major Lupin Limited on Friday announced that its UK subsidiary, Lupin Healthcare (UK) Limited, has received approval from the...
- With new visa norms, practising medicine in UK to become simpler for doctors: British CouncilEarlier the candidates had to clear two separate tests for registering with relevant healthcare regulator in the UK and for immigration pur...
- Marksans Pharma's facility in Goa inspected by UK regulatorThe plant located at Verna has had an inspection by UK Medicines and Healthcare products Regulatory Agency (MHRA) from February 14-17, Mark...
- Zoher Sihorwala to head Wockhardt's regulatory unitMumbai-based pharmaceutical company Wockhardt has appointed Zoher Sihorwala to head its regulatory and compliance division, a senior execut...
- Ranbaxy to recall 3 batches of Pravastatin from UK marketRanbaxy Laboratories is recalling three batches of anticholesterol drug Pravastatin tablets from the UK market for failing to update approv...
- Bafna Pharmaceuticals gets UK MHRA approvalShares of Bafna Pharmaceuticals moved higher after the company got approval from the UK Medicines and Healthcare products Regulatory Agency.
- Aurobindo gets UK MHRA nod for AP manufacturing unitLeading pharmaceutical company Aurobindo Pharma on Friday said it has received the Good Manufacturing Practice clearance certificate from t...
Load More
